期刊文献+

舒洛地特联合辛伐他汀治疗糖尿病下肢血管病变的疗效观察 被引量:2

Clinical Effect Observation of Sulodexide and Simvastatin in Diabetes Patients Complicated with Lower Extremity Venous Disease
下载PDF
导出
摘要 目的观察辛伐他汀联合舒洛地特临床治疗因糖尿病导致的下肢血管病变效果。方法选取该院收治的96例下肢血管病变患者,按照入院先后分为单一组与联合组,每组48例。结果治疗后单一组较联合组患肢疼痛感减轻、间歇性跛行恢复效果差(P<0.05);治疗后联合组较单一组患者血流速度、阻力指数、搏动指数指标恢复好(P<0.05)。结论为有效治疗糖尿病引发的下肢血管病变,改善患者症状,提高治疗效果,临床可采用辛伐他汀与舒洛地特联合用药,患者恢复快、好。 Objective To observe the clinical effect of Simvastatin and Sulodexide in diabetes patients complicated with lower extremity venous disease.Methods 96 diabetes patients complicated with lower extremity venous disease treated in our hospital were selected.The patients were divided into single group and combined group according to the adimission time of hospital,48 cases each group.Results After treatment,the treatment effect of pain and intermittent claudication for combined group was better than that of single group(P〈0.05);after treatment,the recovery of blood flow velocity,resistance index and pulsatility index for combined group was better than that of single group(P〈0.05).Conclusion Simvastatin and Sulodexide has an obvious effect in diabetes patients complicated with lower extremity venous disease,can greatly cure the clinical symptoms,improve the clinical effect and promote the patient's fast recovery.
作者 金禄山
出处 《糖尿病新世界》 2016年第15期33-34,共2页 Diabetes New World Magazine
关键词 血管病变 辛伐他汀 舒洛地特 糖尿病 Venous disease Simvastatin Sulodexide Diabetes
  • 相关文献

参考文献5

二级参考文献53

  • 1谭擎缨,王静,阮芸,余秀华.2型糖尿病下肢血管病变的超声检查及相关因素研究[J].中华糖尿病杂志(1006-6187),2005,13(6):416-417. 被引量:25
  • 2肖春华,罗晓惠,罗平,刘洁玉,迟昆燕,王妍.糖尿病下肢动脉病变的彩色多普勒超声观察[J].中国医学影像学杂志,2007,15(3):238-239. 被引量:12
  • 3周有利,毛达勇,朱名安.2型糖尿病血管并发症患者血清可溶性细胞粘附分子-1和C-反应蛋白的检测分析[J].微循环学杂志,2007,17(2):39-40. 被引量:5
  • 4RONDINA M T, WEYR1CI-I A S. Targeting phosphodiesterases in anti - platelet therapy [ J ]. Handb Exp Pharmacol, 2012 ( 210 ) : 225 - 238. 被引量:1
  • 5SOUSA A G, SELVATICI L, KRIEGER J E, et al. Association between genetics of diabetes, coronary artery disease, and macro- vascular complications: exploring a common ground hypothesis [J]. Rev Diabet Stud, 2011, 8(2) : 230 -244. 被引量:1
  • 6SHEU J J, LINK C, TSAI C Y, et al. Combination of cilostazol and clopidogrel attenuates rat critical limb ischemia [ J ]. J Transl Med, 2012, 10(1) : 164. 被引量:1
  • 7MOHLER E R 3rd. Therapy insight: peripheral arterial disease and diabetes from pathogenesis to treatment guidelines [ J ]. Nat Clin Pract Cardiovasc Med, 2007, 4(3) : 151 -162. 被引量:1
  • 8JI X B, HOU M. Novel agents for anti - platelet therapy [ J ]. J Hematol Oncol, 2011,4: 44. 被引量:1
  • 9RHEESY, KIM Y S, CHON S, et al. Long-term effects of cilostazol on the prevention of macmvascular disease in patients with type 2 diabetes mellitus[ J]. Diabetes Res Clin Pract, 2011, 91(1): e11-e14. 被引量:1
  • 10ROBERTSON L, GHOURI M A, KOVACS F. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion follo- wing peripheral endovascular treatment [ J ]. Cochrane Database Syst Rev, 2012, 8: CD002071. 被引量:1

共引文献46

同被引文献30

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部